CCL2 Chemokine as a Potential Biomarker for Prostate Cancer: A Pilot Study

PURPOSE: Prostate specific antigen is not reliable in diagnosing prostate cancer (PCa), making the identification of novel, precise diagnostic biomarkers important. Since chemokines are associated with more aggressive disease and poor prognosis in diverse malignancies, we aimed to investigate the di...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsaur, Igor, Noack, Anika, Makarevic, Jasmina, Oppermann, Elsie, Waaga-Gasser, Ana Maria, Gasser, Martin, Borgmann, Hendrik, Huesch, Tanja, Gust, Kilian M., Reiter, Michael, Schilling, David, Bartsch, Georg, Haferkamp, Axel, Blaheta, Roman A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398105/
https://www.ncbi.nlm.nih.gov/pubmed/25483747
http://dx.doi.org/10.4143/crt.2014.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398105/
https://www.ncbi.nlm.nih.gov/pubmed/25483747
http://dx.doi.org/10.4143/crt.2014.015

Ejemplares similares